Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

La Jolla seeks patent on MI risk factor identification method

Aug. 23, 1996

FDA grants marketing approval for Biopool's Chromolize tPA Assay Kit

Aug. 23, 1996

Calypte HIV-1 Urine EIA test approved by FDA

Aug. 23, 1996

NeoRx's Verluma approved for U.S. market

Aug. 23, 1996

Conceptus begins clinical testing of STARRT falloposcopy system

Aug. 16, 1996

Home Access HIV testing system cleared for marketing in U.S.

Aug. 16, 1996

BCT launched in U.S.

Aug. 16, 1996

Bard to comarket ProstaScint with Cytogen

Aug. 16, 1996

White Iris leukocyte differential analyzer cleared for U.S. market

Aug. 9, 1996

OncorMed to offer genetic testing for BRC2 mutations

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...